Modular Bioscience

About:

Modular Bioscience develops artificial restriction enzymes for the development of diagnostics and synthetic biology tools.

Website: https://modbiosci.com/

Top Investors: Foothill Ventures

Description:

Modular Bioscience develops artificial restriction enzymes for the development of diagnostics and synthetic biology tools. The company's enzymes are used in the diagnosis of genetic diseases, liquid biopsy, and detection of infectious diseases including COVID-19, enabling users to get early treatment.

Total Funding Amount:

$500000

Headquarters Location:

Palo Alto, California, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)modbiosci.com

Founders:

Huimin Zhao, James Zhang

Number of Employees:

Last Funding Date:

2018-04-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai